2012 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide

2012 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide

235 Amedisys Home Health Care Centers recognized

BATON ROUGE, La.--(BUSINESS WIRE)-- Amedisys, a leading home health care and hospice company (NAS: AMED) , today announced that 235 of its care centers across the country have been named to the 2012 HomeCare Elite™, a compilation of the top-performing home health agencies in the United States compiled annually by OCS Home Care and DecisionHealth. Now in its seventh year, the HomeCare Elite identifies the top 25 percent of agencies and further highlights the top 100 and top 500 agencies overall. Winners are ranked by an analysis of performance measures in quality outcomes, quality improvement and financial performance.

This recognition comes during National Home Care and Hospice Month which is observed in November each year, raising awareness of the importance of home health care throughout the country.

"The 2012 HomeCare Elite winners demonstrate a commitment to providing patient-centered care and serving as leaders in the home health community. Their success offers data-driven proof of being well-managed and high quality care providers to hospitals, managed care organizations, ACOs, and other potential referral partners across the health care continuum," said Susan L. Henricks, president and COO of National Research Corporation, the parent company of OCS HomeCare. "Again, this year, we updated our methodology to reflect the rapidly evolving quality-focused health care landscape and national value-based purchasing trends. We congratulate Amedisys on being one of the top home care agencies in the country."

"Our mission is to provide exceptional at-home care to the communities we serve, and our team of clinical specialists takes great pride in the quality of care and service they provide," said Kate Jones, RN, chief clinical officer of Amedisys Home Health and Hospice. "Making the 2012 HomeCare Elite list is an honor that recognizes our exceptional care teams and their commitment to meeting the greatest needs of our patients in the comfort of their own homes."

The 2012 HomeCare Elite is the only performance recognition of its kind in the home health industry. The 2012 HomeCare Elite is brought to the industry by OCS HomeCare, the leading provider of homecare information, and DecisionHealth, publisher of homecare's most respected independent newsletter Home Health Line. The data used for this analysis were compiled from publicly available information. The entire list of the 2011 HomeCare Elite agencies can be viewed by visiting the OCS HomeCare website at www.ocshomecare.com.

About Amedisys:

Amedisys, Inc. (NAS: AMED) is a leading health care at home company delivering personalized home health and hospice care to more than 360,000 patients each year. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company's state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being one of the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry's first-ever nationwide Care Transitions program, designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient's home health plan of care. For more information about the Company, please visit: http://www.amedisys.com.

About National Research Corporation and OCS HomeCare

OCS HomeCare is a product of National Research Corporation. For more than 30 years, National Corporation (NAS: NRCI) has been at the forefront of patient-centered care. Today the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders.

Currently recognized by Modern Healthcare as the largest patient satisfaction measurement firm in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com.

About DecisionHealth®

For over 30 years, DecisionHealth has served as the leading source for home health news, coding tools and resources, and training materials found in reputable products such as Home Health Line. Our unique blend of award-winning staff journalists and unmatched access to health care executives and industry experts enables DecisionHealth to provide solutions, tools, and guidance that are relied on by nearly 100,000 home health care and specialty physician practice professionals. For more information, please visit www.decisionhealth.com or call 877-602-3835.

Amedisys, Inc.
Kendra Kimmons, 225-299-3720
kendra.kimmons@amedisys.com

KEYWORDS: United States North America Louisiana

INDUSTRY KEYWORDS:

The article 2012 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.